...
首页> 外文期刊>Pediatric diabetes. >Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: The Hvidoere study in young children 2009
【24h】

Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: The Hvidoere study in young children 2009

机译:不同治疗中心的1型糖尿病幼儿的代谢结果有所不同:幼儿的Hvidoere研究2009

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To investigate whether center differences in glycemic control are present in prepubertal children <11yr with type 1 diabetes mellitus. Research Design and Methods: This cross-sectional study involved 18 pediatric centers worldwide. All children, <11 y with a diabetes duration ≥12months were invited to participate. Case Record Forms included information on clinical characteristics, insulin regimens, diabetic ketoacidosis (DKA), severe hypoglycemia, language difficulties, and comorbidities. Hemoglobin A1c (HbA1c) was measured centrally by liquid chromatography (DCCT aligned, range: 4.4-6.3%; IFFC: 25-45mmol/mol). Results: A total of 1133 children participated (mean age: 8.0±2.1 y; females: 47.5%, mean diabetes duration: 3.8±2.1 y). HbA1c (overall mean: 8.0±1.0%; range: 7.3-8.9%) and severe hypoglycemia frequency (mean 21.7 events per 100 patient-years), but not DKA, differed significantly between centers (p<0.001 resp. p=0.179). Language difficulties showed a negative relationship with HbA1c (8.3±1.2% vs. 8.0±1.0%; p = 0.036). Frequency of blood glucose monitoring demonstrated a significant but weak association with HbA1c (r=-0.17; p<0.0001). Although significant different HbA1c levels were obtained with diverse insulin regimens (range: 7.3-8.5%; p<0.001), center differences remained after adjusting for insulin regimen (p<0.001). Differences between insulin regimens were no longer significant after adjusting for center effect (p=0.199). Conclusions: Center differences in metabolic outcomes are present in children <11yr, irrespective of diabetes duration, age, or gender. The incidence of severe hypoglycemia is lower than in adolescents despite achieving better glycemic control. Insulin regimens show a significant relationship with HbA1c but do not explain center differences. Each center's effectiveness in using specific treatment strategies remains the key factor for outcome.
机译:目的:研究青春期<11岁的1型糖尿病儿童的血糖控制中心是否存在差异。研究设计和方法:这项横断面研究涉及全球18个儿科中心。糖尿病持续时间≥12个月的所有<11岁儿童均被邀请参加。病例记录表包括有关临床特征,胰岛素治疗方案,糖尿病性酮症酸中毒(DKA),严重的低血糖症,语言障碍和合并症的信息。血红蛋白A1c(HbA1c)通过液相色谱(DCCT校准,范围:4.4-6.3%; IFFC:25-45mmol / mol)集中测量。结果:共有1133名儿童参加(平均年龄:8.0±2.1岁;女​​性:47.5%,平均糖尿病持续时间:3.8±2.1岁)。 HbA1c(总体平均值:8.0±1.0%;范围:7.3-8.9%)和严重的低血糖发生频率(每100患者-年平均21.7事件),但DKA没有显着差异(p <0.001和p = 0.179) 。语言困难与HbA1c呈负相关(8.3±1.2%对8.0±1.0%; p = 0.036)。血糖监测频率显示与HbA1c有显着但微弱的关联(r = -0.17; p <0.0001)。尽管通过不同的胰岛素治疗方案可获得明显不同的HbA1c水平(范围:7.3-8.5%; p <0.001),但在调整胰岛素治疗方案后仍存在中心差异(p <0.001)。调整中心效应后,胰岛素方案之间的差异不再显着(p = 0.199)。结论:11岁以下儿童的代谢结局存在中心差异,与糖尿病病程,年龄或性别无关。尽管实现了较好的血糖控制,但严重低血糖的发生率仍低于青少年。胰岛素治疗方案与HbA1c有显着关系,但不能解释中心差异。每个中心使用特定治疗策略的有效性仍然是结果的关键因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号